{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:44:41Z","timestamp":1772793881807,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.regpep.2009.12.004","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T09:10:08Z","timestamp":1261041008000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pancreatic \u03b2-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes"],"prefix":"10.1016","volume":"160","author":[{"given":"Meena","family":"Asmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia V.","family":"H\u00f8jberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn F.","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Hare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2009.12.004_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","article-title":"Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets","volume":"32","author":"Lukinius","year":"1989","journal-title":"Diabetologia"},{"issue":"Pt 1","key":"10.1016\/j.regpep.2009.12.004_bib2","first-page":"1","article-title":"Sorting and processing of secretory proteins","volume":"299","author":"Halban","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.regpep.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1083\/jcb.105.1.145","article-title":"Newly synthesized proinsulin\/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway","volume":"105","author":"Rhodes","year":"1987","journal-title":"J Cell Biol"},{"key":"10.1016\/j.regpep.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2337\/diab.35.4.379","article-title":"The limitations to and valid use of C-peptide as a marker of the secretion of insulin","volume":"35","author":"Polonsky","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1464-5491.1993.tb00073.x","article-title":"Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects","volume":"10","author":"van Jaarsveld","year":"1993","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.regpep.2009.12.004_bib6","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2337\/diabetes.51.2007.S117","article-title":"Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?","volume":"51","author":"Gerich","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/diacare.15.5.723","article-title":"Hyperproinsulinemia in type II diabetes","volume":"15","author":"Cohen","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2009.12.004_bib8","first-page":"365","article-title":"Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes","volume":"118","author":"Glaser","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.regpep.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.regpep.2009.12.004_bib10","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib11","first-page":"S2","article-title":"The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes","volume":"13","author":"Triplitt","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.regpep.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","article-title":"Minireview: secondary beta-cell failure in type 2 diabetes \u2014 a convergence of glucotoxicity and lipotoxicity","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00125-008-0943-x","article-title":"Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes","volume":"51","author":"Hojberg","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2009.12.004_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1745-7254.2008.00782.x","article-title":"Increased secretion and expression of amylin in spontaneously diabetic Goto\u2013Kakizaki rats treated with rhGLP-1 (7\u201336)","volume":"29","author":"Weng","year":"2008","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.regpep.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/clinchem\/39.10.2146","article-title":"Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies","volume":"39","author":"Kjems","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.regpep.2009.12.004_bib16","first-page":"3575","article-title":"Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide","volume":"85","author":"Deacon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2009.12.004_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/bj2070381","article-title":"Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33\u201369) of glicentin","volume":"207","author":"Holst","year":"1982","journal-title":"Biochem J"},{"key":"10.1016\/j.regpep.2009.12.004_bib18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2009.12.004_bib19","first-page":"A196","article-title":"New highly specific immunoassays for glucagon-like peptide 1 (GLP-1)","volume":"42","author":"Wilken","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2009.12.004_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","article-title":"The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus","volume":"34","author":"Garvey","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-54-2-217","article-title":"Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics","volume":"54","author":"Hidaka","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","article-title":"The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects","volume":"52","author":"Kjems","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diab.40.2.166","article-title":"Banting Lecture 1990. Beta-cells in type II diabetes mellitus","volume":"40","author":"Porte","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bmj.1.6020.1252","article-title":"Beta-cell function improved by supplementing basal insulin secretion in mild diabetes","volume":"1","author":"Turner","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.regpep.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsboll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.52.7.1786","article-title":"The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose","volume":"52","author":"Chang","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0026-0495(82)90125-1","article-title":"The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia","volume":"31","author":"Vague","year":"1982","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2009.12.004_bib28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-5491.2008.02579.x","article-title":"Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes","volume":"25","author":"Hojberg","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.regpep.2009.12.004_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01228297","article-title":"Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment","volume":"18","author":"Kosaka","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0006-291X(05)81133-7","article-title":"Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats","volume":"180","author":"Gedulin","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00006676-200104000-00013","article-title":"High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets","volume":"22","author":"Gasa","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.regpep.2009.12.004_bib32","first-page":"E300","article-title":"Islet amyloid polypeptide inhibits insulin secretion in conscious rats","volume":"267","author":"Furnsinn","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.regpep.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diab.42.2.330","article-title":"Influence of islet amyloid polypeptide and the 8\u201337 fragment of islet amyloid polypeptide on insulin release from perifused rat islets","volume":"42","author":"Wang","year":"1993","journal-title":"Diabetes"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:17:04Z","timestamp":1759072624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011509002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0167011509002614"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2009.12.004","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic \u03b2-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Regulatory Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regpep.2009.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}